5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one has been researched along with 4-butyrolactone in 1 studies
Studies (5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one) | Trials (5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one) | Recent Studies (post-2010) (5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one) | Studies (4-butyrolactone) | Trials (4-butyrolactone) | Recent Studies (post-2010) (4-butyrolactone) |
---|---|---|---|---|---|
11 | 0 | 1 | 4,456 | 78 | 1,823 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Evans, DL; Figur, LM; Huff, RM; Lahti, RA; Moon, MW | 1 |
1 other study(ies) available for 5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one and 4-butyrolactone
Article | Year |
---|---|
Pre- and postsynaptic dopaminergic activities of U-86170F.
Topics: 4-Butyrolactone; Administration, Oral; Aminoquinolines; Animals; Apomorphine; Dopamine Agents; Injections, Intraperitoneal; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Synapses | 1991 |